existence of a (ductal carcinoma in situ) DCIS-associated premalignant pathway in BRCA mutation carriers. We aimed to examine the prevalence, phenotype and expression of oncodrivers in pure DCIS (pDCIS ... invasive…
Purpose: BRCA1 and BRCA2 mutation carriers develop breast cancers with a tumor phenotype unique from spontaneous tumors. We surveyed known BRCA mutation carriers to determine willingness to be contacted about…
BRCA mutation carriers who are diagnosed with breast cancer can be overwhelmed with decisions. The choice between breast-conserving therapy, mastectomy or a bilateral mastectomy is often the first ... considered when…
molecular status and clinical variables of 32 breast cancer patients with BRCA gene pathogenic mutations carriers and to the histopathological and molecular characteristics of 50 patients affected with breast cancer
respectively). This association was maintained in the subgroup of BRCA1/2 mutation non carriers ... genotypes respectively) and in the subgroup of BRCA1/2 mutation non-carriers with a family history of breast and/or…
Frequency of mutation in alpha-globins gene has a great diversity in different populations, and unlike other hemoglobinopathies is not recognizable by simple biochemical experiments. Carriers of these genes have…
consanguineous marriages. Therefore, the relatively high number of members of the family is carriers of this mutation. Moreover, in this family more than 75 cancer patients were diagnosed. Thus ... possible to postulate…
with well-known links to chronic infection and inflammation were statistically evaluated for carriers of mutations in BRCA1/2 or in related proteins from published studies. Summary risks for known ... site for cancer…
GCase) encoding gene, GBA, which leads to accumulation of glucosylceramide. GD patients and carriers of GD mutations have a significantly higher propensity to develop ParkinsonâÂ?Â?s disease ... that mutant GBA allele…
molecular status and clinical variables of 23 breast cancer patients with BRCA gene mutation carriers and histopathological and molecular characters of breast cancer in 50 patients affected in the same ... patients were…
GCase) encoding gene, GBA, which leads to accumulation of glucosylceramide. GD patients and carriers of GD mutations have a significantly higher propensity to develop Parkinson’s disease (PD) in comparison ... that…
number of HA patients. It is very important to identify women who are carriers of the disease for controlling and reducing the disease. Aim: The aim of this study ... taken from 70 females from 21 unrelated families…
incidence and risk factors for the development of PSC after BSO in BRCA1/2 mutation carriers. Methods: One-hundred-seventeen BRCA1/2 mutation carriers who underwent BSO were evaluated ... STICs. The incidence of PSC…
demonstrate identification of low-penetrant CRC susceptibility loci that modify disease risk in MLH1 mutation carrier. Conclusion: As a result of increasing sample size by expanding international collaborations, we have…
cancer oncogenesis. In our study, miRNA array analysis was performed in high risk-BRCA mutation carrier ovarian cancer family having discordant monozygotic twins for ovarian cancer and family members. Methodology…
portions among the 490 patients, respectively. Gene pairs showing statistically significant mutual exclusivity in mutation carriers are PRSS1 and FANCC (p < 0.01), PRSS1 and PTEN (P < 0.01), and PRSS1 ... oncologists…
used random-effects models Results: Ten cohort studies were included comprising 8087 BRCA1/BRCA2 mutation carriers (2936 surgical and 5151 controls). GRADE assessment certainty of evidence was very low. Overall…
identified compound heterozygous POLR3A mutations in ∼3.1% of index cases. Interestingly, >80% of POLR3A mutation carriers presented the same deep-intronic mutation (c.1909+22G>A), which activates a cryptic
Ovarian Cancer (OC) have BRCA1 mutation and 15% of them with BRCA2 mutation. BRCA1 mutation carriers have an 18% risk (15% for BRCA2 mutation carriers) for developing ... prophylactic measures to activate host immune…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.